MEASUREMENT AND CLINICAL RELEVANCE OF D-DIMER IN THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN ACUTE MYOCARDIAL-INFARCTION

被引：0
|
作者：
HAHN, R [1 ]
MULLERSEYDLITZ, PM [1 ]
MULLER, T [1 ]
HEIMBURG, P [1 ]
机构：
[1] ROBERT BOSCH KRANKENHAUS,D-7000 STUTTGART 50,FED REP GER
来源：
ARTERIOSCLEROSIS | 1988年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A657 / A657
页数：1
相关论文
共 50 条
  • [41] LIMITATION OF MYOCARDIAL-INFARCTION BY EARLY INFUSION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    OROURKE, M
    BARON, D
    KEOGH, A
    KELLY, R
    NELSON, G
    BARNES, C
    RAFTOS, J
    GRAHAM, K
    HILLMAN, K
    NEWMAN, H
    HEALEY, J
    WOOLRIDGE, J
    RIVERS, J
    WHITE, H
    WHITLOCK, R
    NORRIS, R
    CIRCULATION, 1988, 77 (06) : 1311 - 1315
  • [42] CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION
    VANDEWERF, F
    LUDBROOK, PA
    BERGMANN, SR
    TIEFENBRUNN, AJ
    FOX, KAA
    DEGEEST, H
    VERSTRAETE, M
    COLLEN, D
    SOBEL, BE
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (10): : 609 - 613
  • [43] EFFECT OF HEPARIN ADMINISTRATION ON FIBRINOGENOLYSIS DURING THROMBOLYTIC THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION
    SANE, DC
    CALIFF, RM
    SIGMON, KN
    TOPOL, EJ
    STUMP, DC
    FIBRINOLYSIS, 1993, 7 (02) : 103 - 107
  • [44] ANALYSIS OF COAGULATION AND FIBRINOLYSIS AFTER THROMBOLYTIC THERAPY WITH HUMAN TISSUE PLASMINOGEN-ACTIVATOR, MUTANT TISSUE PLASMINOGEN-ACTIVATOR, OR UROKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    IWADE, K
    AOSAKI, M
    OHKI, K
    MATSUMURA, K
    KIMATA, S
    HOSODA, S
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1337 - 1337
  • [45] STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BREWER, CC
    MARKIS, JE
    HEART & LUNG, 1986, 15 (06): : 552 - 558
  • [46] TISSUE PLASMINOGEN-ACTIVATOR - AN EVALUATION OF CLINICAL EFFICACY IN ACUTE MYOCARDIAL-INFARCTION
    ROGERS, SD
    RIEMERSMA, LB
    CLEMENTS, SD
    PHARMACOTHERAPY, 1987, 7 (04): : 111 - 121
  • [47] CHARACTERIZATION OF DOMAIN DELETION AND OR DUPLICATION MUTANTS OF A RECOMBINANT CHIMERA OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA/U-PA)
    NELLES, L
    LIJNEN, HR
    VANNUFFELEN, A
    DEMARSIN, E
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1990, 64 (01) : 53 - 60
  • [48] INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) AND UROKINASE (UK) IN PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION - A MULTICENTER DOUBLE-BLIND, RANDOMIZED TRIAL IN JAPAN
    KANEMOTO, N
    GOTO, Y
    HIROSAWA, K
    KAWAI, C
    KIMATA, S
    YUI, Y
    YAMAMOTO, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1991, 55 (03): : 250 - 261
  • [49] PHARMACOKINETICS AND SYSTEMIC FIBRINOGENOLYTIC EFFECTS OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN HUMANS
    VERSTRAETE, M
    BOUNAMEAUX, H
    DECOCK, F
    VANDEWERF, F
    COLLEN, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 235 (02): : 506 - 512
  • [50] Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue activator of the plasminogen (rt-PA) in patients with acute myocardial infarction
    Nunez, DS
    Santana, SR
    Jimenez, AG
    Mao, MC
    MEDICINA CLINICA, 1997, 108 (08): : 318 - 318
12345